Rematching Anti-Cavid-19s could last a month

When a person is infected with the new coronary, viral protein of the glikoprotenic nature is linked to the ACE2 protein on the surface of human cells writes Express.co.uk.

This process either leads to a person to become a host of the disease, or he gets sick by this virus.

If individuals become immune to the virus, the neutral antibodies block the relationship of glikoprotein proteins of the coronary to the ACE2 protein.

This is supposed to contribute to the immunity of the coronary to the people who recover from Coddy-19.

Dr. Smith set up a new way to test immunity, using a technique called immunoprecipitation revealed by stream quote (IP-FCM).

This approach enables observation of interaction between proteins.

However, unlike the work of blood, which may take three days to test Dr. Smith uses protein made in a laboratory that can detect immunity overnight.

Participants who participated in the research were never hospitalised for the disease and successfully cured by Covid-19, of mild and moderate form.

Using this method I P-FCM, the researcher found that 92 per cent of them had developed antibodies to the disease.

Their immunity was compatible with the average level that was still functional a month after infection.